David Ricks

David Ricks

business United States

David Ricks is the Chief Executive Officer of Eli Lilly and Company, a leading pharmaceutical company known for its innovations in diabetes and weight loss medications, including Zepbound and Mounjaro. Under his leadership, the company announced a significant $27 billion investment to expand its manufacturing capabilities in the United States, aiming to bolster domestic production in response to potential tariffs and supply chain vulnerabilities exposed during the COVID-19 pandemic. Ricks has emphasized the importance of reshoring production and increasing manufacturing capacity to meet the growing demand for Eli Lilly's products.

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
7,304
Power
133$
Sentiment
8.00
Countries Mentioned
Country Mentions Sentiment Dominance + Persistence x Population = Reach x GDP (millions) = Power
Greece 1 8.00 0.07% +0% 10,423,054 7,304 $190,000 133$
Totals 1 10,423,054 7,304 $190,000 133$
Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Ireland Ireland: David Ricks is Eli Lilly’s chief executive who commented on the potential of the new weight-loss pill. 8

The Irish Times – major Irish daily, est. 1859: Lilly’s weight loss pill is a ‘landmark moment’ in the obesity fight – The Irish Times

Ireland Ireland: David Ricks, Eli Lilly’s chief executive, stated that orforglipron may provide a new option for weight management. 8

The Irish Times – major Irish daily, est. 1859: New daily weight-loss pill shows success at clinical trial – The Irish Times

United Kingdom United Kingdom: David Ricks, Eli Lilly’s chief executive, discussed the potential of orforglipron as a new option for weight management. 8

The Guardian: New daily weight-loss pill shows success at clinical trial | Obesity

Denmark Denmark: David Ricks, the CEO of Eli Lilly, stated that orforglipron could provide a new opportunity for people worldwide if approved. 9

Politiken: Novo-rivals vægttabspille består studie som den første af sin slags

Greece Greece: David Ricks, the CEO of Eli Lilly, referred to the new drug as a 'convenient solution, with one pill daily.' 8

Kathimerini: Ερχεται ο αντίπαλος του Ozempic – Νέο χάπι κατά της παχυσαρκίας

United Kingdom United Kingdom: David Ricks, the boss of US pharmaceutical giant Eli Lilly, described the tariffs imposed by Donald Trump as a watershed moment in US economic history. 6

BBC: US pharma boss calls tariffs a ‘pivotal moment'